ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADMA ADMA Biologics Inc

交易中 04-10 11:51:37 EDT

18.41

-0.98

-5.08%

最高19.08	最低18.35	成交量71.18万
今开18.79	昨收19.39	日振幅3.76%
总市值43.73亿	流通市值42.86亿	总股本2.38亿
成交额1,333万	换手率0.31%	流通股本2.33亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADMA","market":"US","secType":"STK","nameCN":"ADMA Biologics Inc","latestPrice":18.405,"timestamp":1744300295039,"preClose":19.39,"halted":0,"volume":711832,"delay":0,"floatShares":232866077,"shares":237615100,"eps":0.809999,"marketStatus":"交易中","change":-0.985,"latestTime":"04-10 11:51:37 EDT","open":18.79,"high":19.08,"low":18.35,"amount":13333215.569872,"amplitude":0.037648,"askPrice":18.42,"askSize":43,"bidPrice":18.4,"bidSize":200,"shortable":3,"etf":0,"ttmEps":0.809999,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1744315200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":19.39,"preHourTrading":{"tag":"盘前","latestPrice":18.8,"preClose":19.39,"latestTime":"09:29 EDT","volume":19926,"amount":377826.25122,"timestamp":1744291799999},"postHourTrading":{"tag":"盘后","latestPrice":19.52,"preClose":19.39,"latestTime":"19:56 EDT","volume":75983,"amount":1473457.939,"timestamp":1744242986856},"volumeRatio":0.563929,"impliedVol":0.793,"impliedVolPercentile":0.8127},"requestUrl":"/m/hq/s/ADMA","defaultTab":"news","newsList":[{"id":"2518244776","title":"Adma Biologics Inc2024财年实现净利润1.98亿美元，同比增加801.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518244776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518244776?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449682,"startTime":"0","endTime":"0","summary":"3月9日，Adma Biologics Inc公布财报，公告显示公司2024财年净利润为1.98亿美元，同比增加801.13%；其中营业收入为4.26亿美元，同比增加65.12%，每股基本收益为0.85美元。从资产负债表来看，Adma Biologics Inc总负债1.38亿美元，其中短期债务1.22百万美元，资产负债比为3.55，流动比率为0.06。机构评级：截至2025年3月9日，当前有3家机构对Adma Biologics Inc目标价做出预测，其中目标均价为27.33美元，其中最低目标价为25.00美元，最高目标价为32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000250abef98ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000250abef98ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA"],"gpt_icon":0},{"id":"2517910218","title":"Adma Biologics Inc盘中异动 急速拉升5.11%报17.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517910218?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:42","pubTimestamp":1741185758,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时42分，Adma Biologics Inc股票出现波动，股价快速上涨5.11%。截至发稿，该股报17.88美元/股，成交量38.2961万股，换手率0.16%，振幅5.35%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.70%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224238a260cb48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224238a260cb48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2516670663","title":"坎托菲茨杰拉德公司：重申ADMA Biologics(ADMA.US)评级，由增持调整至增持评级, 目标价由25.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670663","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516670663?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:54","pubTimestamp":1741100071,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申ADMA Biologics(ADMA.US)评级，由增持调整至增持评级, 目标价由25.00美元调整至25.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04225448522189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADMA"],"gpt_icon":0},{"id":"2516672229","title":"Adma Biologics Inc盘中异动 快速下跌8.47%报14.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516672229?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098761,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Adma Biologics Inc股票出现异动，股价急速下挫8.47%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.25%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223241a25f04e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223241a25f04e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"1116609081","title":"ADMA Biologics 2024年第四季度调整后每股收益（EPS）为0.14美元，低于预期的0.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116609081","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116609081?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:18","pubTimestamp":1741036692,"startTime":"0","endTime":"0","summary":"ADMA Biologics 2024年第四季度调整后每股收益（EPS）为0.14美元，低于预期的0.15美元。以上内容来自Benzinga Earnings专栏，原文如下：ADMA Biologics Q4 2024 Adj. EPS $0.14 Misses $0.15 Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADMA"],"gpt_icon":0},{"id":"1188235161","title":"ADMA Biologics 2024年第四季度 GAAP 每股收益 $0.46，销售额 $117.549M 超过预期 $112.800M","url":"https://stock-news.laohu8.com/highlight/detail?id=1188235161","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188235161?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:08","pubTimestamp":1741036126,"startTime":"0","endTime":"0","summary":"ADMA Biologics 2024年第四季度 GAAP 每股收益 $0.46，销售额 $117.549M 超过预期 $112.800M以上内容来自Benzinga Earnings专栏，原文如下：ADMA Biologics Q4 2024 GAAP EPS $0.46, Sales $117.549M Beat $112.800M Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ADMA Biologics 2024年第四季度 GAAP 每股收益 $0.46，销售额 $117.549M 超过预期 $112.800M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADMA"],"gpt_icon":0},{"id":"2516535309","title":"Adma Biologics Inc盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516535309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516535309?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:26","pubTimestamp":1740774377,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时26分，Adma Biologics Inc股票出现异动，股价大幅上涨5.12%。截至发稿，该股报16.23美元/股，成交量157.227万股，换手率0.67%，振幅6.15%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.41%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301042618a2585202&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301042618a2585202&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"1181224715","title":"异动解读 | ADMA生物技术公司上涨5.21%,财务数据向好或为主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1181224715","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181224715?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:10","pubTimestamp":1736953823,"startTime":"0","endTime":"0","summary":"ADMA Biologics Inc (ADMA) 今日盘中大涨5.21%,引起了市场的广泛关注。\n从公开的财务数据来看,这家生物技术公司最新季度实现营业收入1.2亿美元,净利润3591万美元,每股收益0.15美元,毛利5963万美元,财务数据向好或是推动股价上涨的主因。\n此外,机构评级给予较高评价也值得关注。公开资料显示,100%的分析机构对该股给予买入评级,未有持有或卖出评级,有力支撑了股价上行预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | ADMA生物技术公司上涨5.21%,财务数据向好或为主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADMA"],"gpt_icon":0},{"id":"2503695628","title":"Adma Biologics Inc盘中异动 早盘急速上涨5.39%报17.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503695628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503695628?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951467,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分，Adma Biologics Inc股票出现波动，股价快速上涨5.39%。截至发稿，该股报17.20美元/股，成交量5.1367万股，换手率0.02%，振幅1.89%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.68%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223108a222fd7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223108a222fd7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2503835315","title":"Adma Biologics Inc盘中异动 早盘快速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503835315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503835315?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:34","pubTimestamp":1736778892,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时34分，Adma Biologics Inc股票出现异动，股价快速下跌5.06%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.99%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223452a220405a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223452a220405a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2501278610","title":"Adma Biologics Inc盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501278610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501278610?lang=zh_cn&edition=full","pubTime":"2025-01-07 23:32","pubTimestamp":1736263923,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日23时32分，Adma Biologics Inc股票出现异动，股价急速下挫5.10%。截至发稿，该股报18.16美元/股，成交量45.0653万股，换手率0.19%，振幅5.72%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为1.29%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107233203a218f592&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107233203a218f592&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2500972693","title":"Adma Biologics Inc盘中异动 股价大涨5.07%报18.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500972693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500972693?lang=zh_cn&edition=full","pubTime":"2025-01-03 01:16","pubTimestamp":1735838184,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日01时16分，Adma Biologics Inc股票出现异动，股价快速上涨5.07%。截至发稿，该股报18.02美元/股，成交量65.3496万股，换手率0.28%，振幅5.19%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.70%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103011624ab9c1be1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103011624ab9c1be1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2492382159","title":"Adma Biologics Inc盘中异动 临近收盘快速下挫5.07%报17.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492382159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492382159?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:36","pubTimestamp":1734554165,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时36分，Adma Biologics Inc股票出现波动，股价大幅下挫5.07%。截至发稿，该股报17.68美元/股，成交量158.583万股，换手率0.67%，振幅6.98%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为2.57%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043605ab829ea5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043605ab829ea5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2491351973","title":"Adma Biologics Inc盘中异动 临近收盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491351973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491351973?lang=zh_cn&edition=full","pubTime":"2024-12-13 04:36","pubTimestamp":1734035770,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日04时36分，Adma Biologics Inc股票出现波动，股价快速跳水5.04%。截至发稿，该股报18.64美元/股，成交量132.094万股，换手率0.56%，振幅5.07%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为1.58%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213043611ab73485a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213043611ab73485a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2488774986","title":"Adma Biologics Inc盘中异动 早盘股价大跌5.12%报19.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488774986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488774986?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:48","pubTimestamp":1733150880,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时48分，Adma Biologics Inc股票出现异动，股价急速下跌5.12%。截至发稿，该股报19.08美元/股，成交量53.6204万股，换手率0.23%，振幅4.53%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.09%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224800971b2edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224800971b2edd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2487568297","title":"Adma Biologics Inc盘中异动 早盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487568297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2487568297?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:57","pubTimestamp":1732892229,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时57分，Adma Biologics Inc股票出现异动，股价快速下跌5.15%。截至发稿，该股报20.71美元/股，成交量49.2393万股，换手率0.21%，振幅4.67%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.54%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129225709971aa7f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129225709971aa7f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2484159977","title":"Adma Biologics Inc盘中异动 急速拉升5.02%报20.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484159977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484159977?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:56","pubTimestamp":1732046218,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日03时56分，Adma Biologics Inc股票出现波动，股价大幅拉升5.02%。截至发稿，该股报20.52美元/股，成交量113.842万股，换手率0.48%，振幅6.19%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为1.47%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120035658a2467efa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120035658a2467efa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2484489655","title":"Adma Biologics Inc2024财年第三财季实现净利润35.91百万美元，同比增加1297.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484489655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484489655?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:04","pubTimestamp":1731773092,"startTime":"0","endTime":"0","summary":"11月17日，Adma Biologics Inc公布财报，公告显示公司2024财年第三财季净利润为35.91百万美元，同比增加1297.28%；其中营业收入为1.20亿美元，同比增加78.39%，每股基本收益为0.15美元。从资产负债表来看，Adma Biologics Inc总负债1.59亿美元，其中短期债务1.19百万美元，资产负债比为2.46，流动比率为0.08。机构评级：截至2024年11月17日，当前有4家机构对Adma Biologics Inc目标价做出预测，其中目标均价为25.00美元，其中最低目标价为24.00美元，最高目标价为26.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000622a23e0835&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000622a23e0835&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA"],"gpt_icon":0},{"id":"2483302306","title":"Adma Biologics Inc盘中异动 急速跳水5.00%报19.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483302306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483302306?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:50","pubTimestamp":1731689418,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日00时50分，Adma Biologics Inc股票出现异动，股价大幅下挫5.00%。截至发稿，该股报19.19美元/股，成交量157.09万股，换手率0.66%，振幅5.35%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为3.81%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116005018abc532c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116005018abc532c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2483332798","title":"Adma Biologics Inc盘中异动 临近收盘股价大跌5.12%报20.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483332798?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:44","pubTimestamp":1731617097,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时44分，Adma Biologics Inc股票出现异动，股价急速下跌5.12%。截至发稿，该股报20.37美元/股，成交量215.088万股，换手率0.91%，振幅4.35%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为1.93%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115044457971a6a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115044457971a6a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.admabiologics.com","stockEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":0.1674},{"period":"3month","weight":0.0447},{"period":"6month","weight":0.1309},{"period":"1year","weight":2.1735},{"period":"ytd","weight":0.1306}],"compareEarnings":[{"period":"1week","weight":-0.0282},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0693},{"period":"6month","weight":-0.0534},{"period":"1year","weight":0.0564},{"period":"ytd","weight":-0.0639}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ADMA Biologics, Inc.于2004年6月24日在新泽西州注册成立。该公司是一家端到端的商业生物制药公司，致力于制造、营销和开发专门的生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有特定传染病风险的人。该公司的目标患者群体包括患有潜在免疫缺陷疾病或可能因医疗原因而受到免疫抑制的免疫功能受损个体。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.027611},{"month":2,"riseRate":0.545455,"avgChangeRate":-0.01132},{"month":3,"riseRate":0.636364,"avgChangeRate":0.108134},{"month":4,"riseRate":0.545455,"avgChangeRate":0.004599},{"month":5,"riseRate":0.7,"avgChangeRate":0.076004},{"month":6,"riseRate":0.2,"avgChangeRate":-0.053782},{"month":7,"riseRate":0.7,"avgChangeRate":0.113035},{"month":8,"riseRate":0.3,"avgChangeRate":0.011317},{"month":9,"riseRate":0.2,"avgChangeRate":-0.020319},{"month":10,"riseRate":0.4,"avgChangeRate":-0.051308},{"month":11,"riseRate":0.6,"avgChangeRate":0.079185},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.06159}],"exchange":"NASDAQ","name":"ADMA Biologics Inc","nameEN":"ADMA Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.2","shortVersion":"4.32.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ADMA Biologics Inc(ADMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ADMA Biologics Inc,ADMA,ADMA Biologics Inc股票,ADMA Biologics Inc股票老虎,ADMA Biologics Inc股票老虎国际,ADMA Biologics Inc行情,ADMA Biologics Inc股票行情,ADMA Biologics Inc股价,ADMA Biologics Inc股市,ADMA Biologics Inc股票价格,ADMA Biologics Inc股票交易,ADMA Biologics Inc股票购买,ADMA Biologics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ADMA Biologics Inc(ADMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}